nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Ototoxicity—Vinorelbine—lung cancer	0.0405	0.0405	CcSEcCtD
Capreomycin—Nephrotoxicity—Teniposide—lung cancer	0.0403	0.0403	CcSEcCtD
Capreomycin—Ototoxicity—Cisplatin—lung cancer	0.0303	0.0303	CcSEcCtD
Capreomycin—Nephritis—Erlotinib—lung cancer	0.0275	0.0275	CcSEcCtD
Capreomycin—Ototoxicity—Paclitaxel—lung cancer	0.0273	0.0273	CcSEcCtD
Capreomycin—Hypomagnesaemia—Gefitinib—lung cancer	0.0248	0.0248	CcSEcCtD
Capreomycin—Ototoxicity—Docetaxel—lung cancer	0.0231	0.0231	CcSEcCtD
Capreomycin—Nephropathy toxic—Teniposide—lung cancer	0.0223	0.0223	CcSEcCtD
Capreomycin—Abscess—Crizotinib—lung cancer	0.0219	0.0219	CcSEcCtD
Capreomycin—Nephrotoxicity—Cisplatin—lung cancer	0.0192	0.0192	CcSEcCtD
Capreomycin—Foetor hepaticus—Erlotinib—lung cancer	0.0166	0.0166	CcSEcCtD
Capreomycin—Nephropathy toxic—Vinorelbine—lung cancer	0.0142	0.0142	CcSEcCtD
Capreomycin—Liver disorder—Erlotinib—lung cancer	0.0138	0.0138	CcSEcCtD
Capreomycin—Induration—Etoposide—lung cancer	0.0125	0.0125	CcSEcCtD
Capreomycin—Induration—Paclitaxel—lung cancer	0.0122	0.0122	CcSEcCtD
Capreomycin—Hypokalaemia—Crizotinib—lung cancer	0.0114	0.0114	CcSEcCtD
Capreomycin—Nephropathy toxic—Gemcitabine—lung cancer	0.0114	0.0114	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—lung cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Nephropathy toxic—Cisplatin—lung cancer	0.0106	0.0106	CcSEcCtD
Capreomycin—Hypomagnesaemia—Irinotecan—lung cancer	0.0106	0.0106	CcSEcCtD
Capreomycin—Hypokalaemia—Gefitinib—lung cancer	0.0104	0.0104	CcSEcCtD
Capreomycin—Hypomagnesaemia—Gemcitabine—lung cancer	0.0103	0.0103	CcSEcCtD
Capreomycin—Nephropathy toxic—Etoposide—lung cancer	0.00972	0.00972	CcSEcCtD
Capreomycin—Nephropathy toxic—Paclitaxel—lung cancer	0.00953	0.00953	CcSEcCtD
Capreomycin—Hepatocellular injury—Erlotinib—lung cancer	0.00941	0.00941	CcSEcCtD
Capreomycin—Renal failure—Pemetrexed—lung cancer	0.00871	0.00871	CcSEcCtD
Capreomycin—Hypomagnesaemia—Paclitaxel—lung cancer	0.00861	0.00861	CcSEcCtD
Capreomycin—Hearing impaired—Vinorelbine—lung cancer	0.00854	0.00854	CcSEcCtD
Capreomycin—Foetor hepaticus—Docetaxel—lung cancer	0.00817	0.00817	CcSEcCtD
Capreomycin—Deafness—Vinblastine—lung cancer	0.00794	0.00794	CcSEcCtD
Capreomycin—Abscess—Cisplatin—lung cancer	0.0077	0.0077	CcSEcCtD
Capreomycin—Renal impairment—Erlotinib—lung cancer	0.00718	0.00718	CcSEcCtD
Capreomycin—Hypocalcaemia—Gemcitabine—lung cancer	0.00714	0.00714	CcSEcCtD
Capreomycin—Hearing impaired—Gemcitabine—lung cancer	0.00686	0.00686	CcSEcCtD
Capreomycin—Liver disorder—Docetaxel—lung cancer	0.0068	0.0068	CcSEcCtD
Capreomycin—Leukopenia—Crizotinib—lung cancer	0.00678	0.00678	CcSEcCtD
Capreomycin—Deafness—Vinorelbine—lung cancer	0.0066	0.0066	CcSEcCtD
Capreomycin—Hearing impaired—Cisplatin—lung cancer	0.0064	0.0064	CcSEcCtD
Capreomycin—Hypokalaemia—Erlotinib—lung cancer	0.00621	0.00621	CcSEcCtD
Capreomycin—Leukopenia—Pemetrexed—lung cancer	0.0062	0.0062	CcSEcCtD
Capreomycin—Hepatocellular injury—Cisplatin—lung cancer	0.00609	0.00609	CcSEcCtD
Capreomycin—Hypocalcaemia—Paclitaxel—lung cancer	0.00598	0.00598	CcSEcCtD
Capreomycin—Hearing impaired—Paclitaxel—lung cancer	0.00575	0.00575	CcSEcCtD
Capreomycin—Thrombocytopenia—Pemetrexed—lung cancer	0.00553	0.00553	CcSEcCtD
Capreomycin—Thrombocytopenia—Gefitinib—lung cancer	0.0055	0.0055	CcSEcCtD
Capreomycin—Deafness—Gemcitabine—lung cancer	0.0053	0.0053	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—lung cancer	0.00523	0.00523	CcSEcCtD
Capreomycin—Renal failure—Erlotinib—lung cancer	0.00517	0.00517	CcSEcCtD
Capreomycin—Renal impairment—Irinotecan—lung cancer	0.00512	0.00512	CcSEcCtD
Capreomycin—Oliguria—Docetaxel—lung cancer	0.00503	0.00503	CcSEcCtD
Capreomycin—Leukopenia—Teniposide—lung cancer	0.00502	0.00502	CcSEcCtD
Capreomycin—Renal impairment—Gemcitabine—lung cancer	0.00498	0.00498	CcSEcCtD
Capreomycin—Deafness—Cisplatin—lung cancer	0.00494	0.00494	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—lung cancer	0.00492	0.00492	CcSEcCtD
Capreomycin—Liver disorder—Methotrexate—lung cancer	0.0049	0.0049	CcSEcCtD
Capreomycin—Body temperature increased—Crizotinib—lung cancer	0.00489	0.00489	CcSEcCtD
Capreomycin—Hearing impaired—Docetaxel—lung cancer	0.00487	0.00487	CcSEcCtD
Capreomycin—Pain—Pemetrexed—lung cancer	0.00483	0.00483	CcSEcCtD
Capreomycin—Pain—Gefitinib—lung cancer	0.0048	0.0048	CcSEcCtD
Capreomycin—Hepatocellular injury—Docetaxel—lung cancer	0.00464	0.00464	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—lung cancer	0.00456	0.00456	CcSEcCtD
Capreomycin—Urticaria—Pemetrexed—lung cancer	0.00449	0.00449	CcSEcCtD
Capreomycin—Thrombocytopenia—Teniposide—lung cancer	0.00448	0.00448	CcSEcCtD
Capreomycin—Body temperature increased—Pemetrexed—lung cancer	0.00447	0.00447	CcSEcCtD
Capreomycin—Urticaria—Gefitinib—lung cancer	0.00446	0.00446	CcSEcCtD
Capreomycin—Deafness—Paclitaxel—lung cancer	0.00444	0.00444	CcSEcCtD
Capreomycin—Body temperature increased—Gefitinib—lung cancer	0.00444	0.00444	CcSEcCtD
Capreomycin—Hypokalaemia—Irinotecan—lung cancer	0.00443	0.00443	CcSEcCtD
Capreomycin—Hypokalaemia—Gemcitabine—lung cancer	0.00432	0.00432	CcSEcCtD
Capreomycin—Abscess—Methotrexate—lung cancer	0.00422	0.00422	CcSEcCtD
Capreomycin—Renal impairment—Paclitaxel—lung cancer	0.00417	0.00417	CcSEcCtD
Capreomycin—Hypersensitivity—Pemetrexed—lung cancer	0.00416	0.00416	CcSEcCtD
Capreomycin—Hypersensitivity—Gefitinib—lung cancer	0.00414	0.00414	CcSEcCtD
Capreomycin—Hypokalaemia—Cisplatin—lung cancer	0.00402	0.00402	CcSEcCtD
Capreomycin—Rash—Crizotinib—lung cancer	0.0039	0.0039	CcSEcCtD
Capreomycin—Dermatitis—Crizotinib—lung cancer	0.00389	0.00389	CcSEcCtD
Capreomycin—Vertigo—Vinblastine—lung cancer	0.00384	0.00384	CcSEcCtD
Capreomycin—Leukopenia—Vinblastine—lung cancer	0.00383	0.00383	CcSEcCtD
Capreomycin—Deafness—Docetaxel—lung cancer	0.00376	0.00376	CcSEcCtD
Capreomycin—Leukopenia—Topotecan—lung cancer	0.00372	0.00372	CcSEcCtD
Capreomycin—Renal failure—Irinotecan—lung cancer	0.00369	0.00369	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—lung cancer	0.00366	0.00366	CcSEcCtD
Capreomycin—Urticaria—Teniposide—lung cancer	0.00364	0.00364	CcSEcCtD
Capreomycin—Oliguria—Methotrexate—lung cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Body temperature increased—Teniposide—lung cancer	0.00362	0.00362	CcSEcCtD
Capreomycin—Hypokalaemia—Paclitaxel—lung cancer	0.00361	0.00361	CcSEcCtD
Capreomycin—Renal failure—Gemcitabine—lung cancer	0.00359	0.00359	CcSEcCtD
Capreomycin—Rash—Pemetrexed—lung cancer	0.00356	0.00356	CcSEcCtD
Capreomycin—Dermatitis—Pemetrexed—lung cancer	0.00356	0.00356	CcSEcCtD
Capreomycin—Rash—Gefitinib—lung cancer	0.00354	0.00354	CcSEcCtD
Capreomycin—Renal impairment—Docetaxel—lung cancer	0.00354	0.00354	CcSEcCtD
Capreomycin—Dermatitis—Gefitinib—lung cancer	0.00354	0.00354	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinblastine—lung cancer	0.00342	0.00342	CcSEcCtD
Capreomycin—Hypersensitivity—Teniposide—lung cancer	0.00337	0.00337	CcSEcCtD
Capreomycin—Renal failure—Cisplatin—lung cancer	0.00335	0.00335	CcSEcCtD
Capreomycin—Thrombocytopenia—Topotecan—lung cancer	0.00332	0.00332	CcSEcCtD
Capreomycin—Thrombocytopenia—Erlotinib—lung cancer	0.00329	0.00329	CcSEcCtD
Capreomycin—Vertigo—Vinorelbine—lung cancer	0.00319	0.00319	CcSEcCtD
Capreomycin—Leukopenia—Vinorelbine—lung cancer	0.00318	0.00318	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—lung cancer	0.00316	0.00316	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—lung cancer	0.00314	0.00314	CcSEcCtD
Capreomycin—Renal failure—Etoposide—lung cancer	0.00307	0.00307	CcSEcCtD
Capreomycin—Renal failure—Paclitaxel—lung cancer	0.00301	0.00301	CcSEcCtD
Capreomycin—Pain—Vinblastine—lung cancer	0.00299	0.00299	CcSEcCtD
Capreomycin—Pain—Topotecan—lung cancer	0.0029	0.0029	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—lung cancer	0.00289	0.00289	CcSEcCtD
Capreomycin—Rash—Teniposide—lung cancer	0.00289	0.00289	CcSEcCtD
Capreomycin—Dermatitis—Teniposide—lung cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Pain—Erlotinib—lung cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Tinnitus—Cisplatin—lung cancer	0.00285	0.00285	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinorelbine—lung cancer	0.00284	0.00284	CcSEcCtD
Capreomycin—Urticaria—Topotecan—lung cancer	0.00269	0.00269	CcSEcCtD
Capreomycin—Body temperature increased—Topotecan—lung cancer	0.00268	0.00268	CcSEcCtD
Capreomycin—Body temperature increased—Erlotinib—lung cancer	0.00265	0.00265	CcSEcCtD
Capreomycin—Vertigo—Irinotecan—lung cancer	0.00263	0.00263	CcSEcCtD
Capreomycin—Leukopenia—Irinotecan—lung cancer	0.00262	0.00262	CcSEcCtD
Capreomycin—Hypersensitivity—Vinblastine—lung cancer	0.00257	0.00257	CcSEcCtD
Capreomycin—Tinnitus—Paclitaxel—lung cancer	0.00256	0.00256	CcSEcCtD
Capreomycin—Leukopenia—Gemcitabine—lung cancer	0.00256	0.00256	CcSEcCtD
Capreomycin—Renal failure—Docetaxel—lung cancer	0.00255	0.00255	CcSEcCtD
Capreomycin—Hypersensitivity—Topotecan—lung cancer	0.0025	0.0025	CcSEcCtD
Capreomycin—Pain—Vinorelbine—lung cancer	0.00248	0.00248	CcSEcCtD
Capreomycin—Leukopenia—Cisplatin—lung cancer	0.00238	0.00238	CcSEcCtD
Capreomycin—Thrombocytopenia—Irinotecan—lung cancer	0.00234	0.00234	CcSEcCtD
Capreomycin—Urticaria—Vinorelbine—lung cancer	0.00231	0.00231	CcSEcCtD
Capreomycin—Body temperature increased—Vinorelbine—lung cancer	0.00229	0.00229	CcSEcCtD
Capreomycin—Thrombocytopenia—Gemcitabine—lung cancer	0.00228	0.00228	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—lung cancer	0.00221	0.00221	CcSEcCtD
Capreomycin—Vertigo—Etoposide—lung cancer	0.00219	0.00219	CcSEcCtD
Capreomycin—Leukopenia—Etoposide—lung cancer	0.00218	0.00218	CcSEcCtD
Capreomycin—Vertigo—Paclitaxel—lung cancer	0.00215	0.00215	CcSEcCtD
Capreomycin—Leukopenia—Paclitaxel—lung cancer	0.00214	0.00214	CcSEcCtD
Capreomycin—Rash—Topotecan—lung cancer	0.00214	0.00214	CcSEcCtD
Capreomycin—Hypersensitivity—Vinorelbine—lung cancer	0.00214	0.00214	CcSEcCtD
Capreomycin—Dermatitis—Topotecan—lung cancer	0.00214	0.00214	CcSEcCtD
Capreomycin—Thrombocytopenia—Cisplatin—lung cancer	0.00213	0.00213	CcSEcCtD
Capreomycin—Rash—Erlotinib—lung cancer	0.00212	0.00212	CcSEcCtD
Capreomycin—Dermatitis—Erlotinib—lung cancer	0.00211	0.00211	CcSEcCtD
Capreomycin—Eosinophilia—Methotrexate—lung cancer	0.00208	0.00208	CcSEcCtD
Capreomycin—Pain—Irinotecan—lung cancer	0.00205	0.00205	CcSEcCtD
Capreomycin—Pain—Gemcitabine—lung cancer	0.00199	0.00199	CcSEcCtD
Capreomycin—Thrombocytopenia—Etoposide—lung cancer	0.00195	0.00195	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—lung cancer	0.00191	0.00191	CcSEcCtD
Capreomycin—Thrombocytopenia—Paclitaxel—lung cancer	0.00191	0.00191	CcSEcCtD
Capreomycin—Body temperature increased—Irinotecan—lung cancer	0.00189	0.00189	CcSEcCtD
Capreomycin—Pain—Cisplatin—lung cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Body temperature increased—Gemcitabine—lung cancer	0.00184	0.00184	CcSEcCtD
Capreomycin—Renal failure—Methotrexate—lung cancer	0.00184	0.00184	CcSEcCtD
Capreomycin—Rash—Vinorelbine—lung cancer	0.00183	0.00183	CcSEcCtD
Capreomycin—Dermatitis—Vinorelbine—lung cancer	0.00183	0.00183	CcSEcCtD
Capreomycin—Leukopenia—Docetaxel—lung cancer	0.00181	0.00181	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—lung cancer	0.0018	0.0018	CcSEcCtD
Capreomycin—Hypersensitivity—Irinotecan—lung cancer	0.00176	0.00176	CcSEcCtD
Capreomycin—Body temperature increased—Cisplatin—lung cancer	0.00172	0.00172	CcSEcCtD
Capreomycin—Pain—Etoposide—lung cancer	0.0017	0.0017	CcSEcCtD
Capreomycin—Pain—Paclitaxel—lung cancer	0.00167	0.00167	CcSEcCtD
Capreomycin—Thrombocytopenia—Docetaxel—lung cancer	0.00162	0.00162	CcSEcCtD
Capreomycin—Hypersensitivity—Cisplatin—lung cancer	0.0016	0.0016	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—lung cancer	0.00159	0.00159	CcSEcCtD
Capreomycin—Urticaria—Etoposide—lung cancer	0.00158	0.00158	CcSEcCtD
Capreomycin—Body temperature increased—Etoposide—lung cancer	0.00157	0.00157	CcSEcCtD
Capreomycin—Tinnitus—Methotrexate—lung cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Urticaria—Paclitaxel—lung cancer	0.00155	0.00155	CcSEcCtD
Capreomycin—Body temperature increased—Paclitaxel—lung cancer	0.00154	0.00154	CcSEcCtD
Capreomycin—Rash—Irinotecan—lung cancer	0.00151	0.00151	CcSEcCtD
Capreomycin—Dermatitis—Irinotecan—lung cancer	0.00151	0.00151	CcSEcCtD
Capreomycin—Rash—Gemcitabine—lung cancer	0.00147	0.00147	CcSEcCtD
Capreomycin—Dermatitis—Gemcitabine—lung cancer	0.00147	0.00147	CcSEcCtD
Capreomycin—Hypersensitivity—Etoposide—lung cancer	0.00147	0.00147	CcSEcCtD
Capreomycin—Hypersensitivity—Paclitaxel—lung cancer	0.00144	0.00144	CcSEcCtD
Capreomycin—Pain—Docetaxel—lung cancer	0.00141	0.00141	CcSEcCtD
Capreomycin—Rash—Cisplatin—lung cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Dermatitis—Cisplatin—lung cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—lung cancer	0.00136	0.00136	CcSEcCtD
Capreomycin—Vertigo—Methotrexate—lung cancer	0.00131	0.00131	CcSEcCtD
Capreomycin—Body temperature increased—Docetaxel—lung cancer	0.00131	0.00131	CcSEcCtD
Capreomycin—Leukopenia—Methotrexate—lung cancer	0.00131	0.00131	CcSEcCtD
Capreomycin—Rash—Etoposide—lung cancer	0.00126	0.00126	CcSEcCtD
Capreomycin—Dermatitis—Etoposide—lung cancer	0.00125	0.00125	CcSEcCtD
Capreomycin—Rash—Paclitaxel—lung cancer	0.00123	0.00123	CcSEcCtD
Capreomycin—Dermatitis—Paclitaxel—lung cancer	0.00123	0.00123	CcSEcCtD
Capreomycin—Hypersensitivity—Docetaxel—lung cancer	0.00122	0.00122	CcSEcCtD
Capreomycin—Thrombocytopenia—Methotrexate—lung cancer	0.00117	0.00117	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—lung cancer	0.00114	0.00114	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—lung cancer	0.00113	0.00113	CcSEcCtD
Capreomycin—Rash—Docetaxel—lung cancer	0.00104	0.00104	CcSEcCtD
Capreomycin—Dermatitis—Docetaxel—lung cancer	0.00104	0.00104	CcSEcCtD
Capreomycin—Pain—Methotrexate—lung cancer	0.00102	0.00102	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—lung cancer	0.00101	0.00101	CcSEcCtD
Capreomycin—Urticaria—Methotrexate—lung cancer	0.000947	0.000947	CcSEcCtD
Capreomycin—Body temperature increased—Methotrexate—lung cancer	0.000943	0.000943	CcSEcCtD
Capreomycin—Pain—Doxorubicin—lung cancer	0.000883	0.000883	CcSEcCtD
Capreomycin—Hypersensitivity—Methotrexate—lung cancer	0.000879	0.000879	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—lung cancer	0.00082	0.00082	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—lung cancer	0.000816	0.000816	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—lung cancer	0.000761	0.000761	CcSEcCtD
Capreomycin—Rash—Methotrexate—lung cancer	0.000752	0.000752	CcSEcCtD
Capreomycin—Dermatitis—Methotrexate—lung cancer	0.000751	0.000751	CcSEcCtD
Capreomycin—Rash—Doxorubicin—lung cancer	0.000651	0.000651	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—lung cancer	0.00065	0.00065	CcSEcCtD
